IL162857A0 - Oral vaccination - Google Patents
Oral vaccinationInfo
- Publication number
- IL162857A0 IL162857A0 IL16285703A IL16285703A IL162857A0 IL 162857 A0 IL162857 A0 IL 162857A0 IL 16285703 A IL16285703 A IL 16285703A IL 16285703 A IL16285703 A IL 16285703A IL 162857 A0 IL162857 A0 IL 162857A0
- Authority
- IL
- Israel
- Prior art keywords
- vaccination
- oral vaccination
- oral
- drug
- simultaneous
- Prior art date
Links
- 238000002255 vaccination Methods 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Materials For Photolithography (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02000901A EP1327450B1 (de) | 2002-01-15 | 2002-01-15 | Orale Vakzinierung mit nackten Tumor-Antigen-Mimotopen |
| DE10259053A DE10259053A1 (de) | 2002-12-17 | 2002-12-17 | Antigen-Mimotope und Vakzine gegen Krebserkrankungen |
| PCT/EP2003/000369 WO2003059380A2 (de) | 2002-01-15 | 2003-01-15 | Orale vakzinierung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL162857A0 true IL162857A0 (en) | 2005-11-20 |
Family
ID=26011230
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16285703A IL162857A0 (en) | 2002-01-15 | 2003-01-15 | Oral vaccination |
| IL162857A IL162857A (en) | 2002-01-15 | 2004-07-05 | Use of an antigentically active substance and a gastric acid reducing substance for producing a vaccine for tumoral diseases |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL162857A IL162857A (en) | 2002-01-15 | 2004-07-05 | Use of an antigentically active substance and a gastric acid reducing substance for producing a vaccine for tumoral diseases |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20050226894A1 (xx) |
| EP (1) | EP1465658B1 (xx) |
| AT (1) | ATE361097T1 (xx) |
| AU (1) | AU2003212215B9 (xx) |
| CA (1) | CA2473416A1 (xx) |
| DE (1) | DE50307169D1 (xx) |
| ES (1) | ES2286409T3 (xx) |
| IL (2) | IL162857A0 (xx) |
| WO (1) | WO2003059380A2 (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6967457B2 (ja) * | 2016-02-02 | 2021-11-17 | 日東電工株式会社 | 免疫誘導促進用組成物及びワクチン医薬組成物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US471353A (en) * | 1892-03-22 | Can-testing machine | ||
| ATE433325T1 (de) * | 1995-04-28 | 2009-06-15 | Merieux Oravax Snc | Multimerer, rekombinanter urease impfstoff |
| US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
| SE9600648D0 (sv) * | 1996-02-21 | 1996-02-21 | Bror Morein | Receptorbimdande enhet |
| HUP9901109A3 (en) * | 1996-03-01 | 1999-11-29 | Novartis Ag | Peptide immunogens for vaccination against and treatment of allergy |
| US6403098B1 (en) * | 1996-09-26 | 2002-06-11 | Merck & Co., Inc. | Rotavirus vaccine formulations |
| WO1998043479A1 (en) * | 1997-04-01 | 1998-10-08 | Merieux Oravax | 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES |
| WO1999007869A1 (en) * | 1997-08-05 | 1999-02-18 | University Of Florida | Live recombinant vaccine comprising inefficiently or non-replicating virus |
| GB0020089D0 (en) * | 2000-08-15 | 2000-10-04 | Smithkline Beecham Biolog | Vaccine Composition |
| US6497859B1 (en) * | 2000-11-17 | 2002-12-24 | Noville Inc. | Cooling agents, pharmaceutical compositions having cooling agents and processes for making and using same |
| BRPI0207447B1 (pt) * | 2001-02-21 | 2015-09-22 | Id Biomedical Corp | polipeptídeo recombinante isolado, seu uso e processo de produção, vetor de expressão, célula hospedeira microbiana transgênica, composição farmacêutica, uso da dita composição, métodos de detecção e kit |
| EP1327450B1 (de) * | 2002-01-15 | 2007-08-15 | Bio Life Science Forschungs- und Entwicklungsges.m.b.H. | Orale Vakzinierung mit nackten Tumor-Antigen-Mimotopen |
-
2003
- 2003-01-15 AU AU2003212215A patent/AU2003212215B9/en not_active Ceased
- 2003-01-15 IL IL16285703A patent/IL162857A0/xx active IP Right Grant
- 2003-01-15 WO PCT/EP2003/000369 patent/WO2003059380A2/de active IP Right Grant
- 2003-01-15 US US10/501,402 patent/US20050226894A1/en not_active Abandoned
- 2003-01-15 EP EP03708059A patent/EP1465658B1/de not_active Expired - Lifetime
- 2003-01-15 AT AT03708059T patent/ATE361097T1/de active
- 2003-01-15 CA CA002473416A patent/CA2473416A1/en not_active Abandoned
- 2003-01-15 DE DE50307169T patent/DE50307169D1/de not_active Expired - Lifetime
- 2003-01-15 ES ES03708059T patent/ES2286409T3/es not_active Expired - Lifetime
-
2004
- 2004-07-05 IL IL162857A patent/IL162857A/en not_active IP Right Cessation
-
2010
- 2010-02-01 US US12/656,491 patent/US20100183684A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003212215A1 (en) | 2003-07-30 |
| DE50307169D1 (de) | 2007-06-14 |
| ATE361097T1 (de) | 2007-05-15 |
| CA2473416A1 (en) | 2003-07-24 |
| AU2003212215B2 (en) | 2007-10-11 |
| WO2003059380A2 (de) | 2003-07-24 |
| US20100183684A1 (en) | 2010-07-22 |
| EP1465658A2 (de) | 2004-10-13 |
| ES2286409T3 (es) | 2007-12-01 |
| IL162857A (en) | 2011-03-31 |
| US20050226894A1 (en) | 2005-10-13 |
| WO2003059380A3 (de) | 2004-01-22 |
| AU2003212215B9 (en) | 2008-02-21 |
| EP1465658B1 (de) | 2007-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| MXPA03007712A (es) | Sales farmaceuticas. | |
| UA96449C2 (xx) | Стабільні препарати лаквінімоду$стабильные препараты лаквинимода | |
| IL164798A0 (en) | Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| WO2004055006A8 (en) | Novel compounds having selective inhibiting effect at gsk3 | |
| HK1076605A1 (en) | Formulations | |
| AP1787A (en) | Novel perindopril salt and pharmaceutical compositions containing same. | |
| NO20062605L (no) | Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper | |
| ATE260650T1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
| WO2004091591A3 (fr) | Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives | |
| AU2003246567A1 (en) | Administration form for the oral administration of active substances, vitamins, and/or nutrients | |
| GR20020100478A (el) | Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης | |
| TW200509992A (en) | Dosage form containing pantoprazole as active ingredient | |
| AU2003208673A1 (en) | Pacifier for administering flavour substances | |
| EP1669065A4 (en) | DRUGS WITH (2R) -2-PROPYLOCTANIC ACID AS ACTIVE SUBSTANCE | |
| TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
| AU2003246566A1 (en) | Administration form for the oral administration of active substances, vitamins, and/or nutrients | |
| EP1273301A3 (en) | Pharmaceutical preparations based on active ingredients susceptible to illict administration | |
| AP2001002369A0 (en) | Pharmaceutical complex. | |
| IL162857A0 (en) | Oral vaccination | |
| ZA200204905B (en) | Improved pharmaceutical dental formulations. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |